{"gene":"PF3D7_1228600","run_date":"2026-09-08T14:19:06","timeline":{"discoveries":[{"year":2003,"finding":"Two regions of MSP9 (MSP9/Delta1 and MSP9/Delta2) interact directly with the 5ABC exofacial region of erythrocyte band 3 during P. falciparum erythrocyte invasion. Soluble 5ABC blocked MSP9 binding to erythrocytes, and recombinant MSP9/Delta1 and MSP9/Delta2 inhibited P. falciparum reinvasion in vitro. Native MSP9 and MSP1(42) exist as a stable co-ligand complex that together targets the band 3 receptor.","method":"Recombinant protein binding assays, erythrocyte invasion inhibition assay, co-immunoprecipitation of native proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding assays with recombinant and native protein, functional invasion inhibition, soluble competitor blocking, replicated across multiple MSP9 constructs in a single rigorous study","pmids":["14630931"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"finding":"A major MSP9-binding site on MSP1 is located within the 19 kDa C-terminal domain (MSP1(19)). Two specific regions of MSP9, Delta1a and Delta2, interact with native MSP1(19) and with MSP1(42). The regions of MSP1 and MSP9 that bind the erythrocyte band 3 receptor are the same regions responsible for assembling the co-ligand complex, forming a ternary complex of MSP1–MSP9–band 3 during invasion.","method":"Biochemical pulldown/binding assays with recombinant MSP9 deletion constructs and native MSP1(19)/MSP1(42)","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple deletion constructs with reciprocal binding assays, building directly on prior replicated results; single lab but two orthogonal binding approaches","pmids":["16289042"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"finding":"The amino terminus of MSP9 (also called ABRA) interacts with erythrocyte band 3 protein in a dose-dependent and saturable manner. Among band 3, glycophorin A, glycophorin B, and spectrin, only band 3 bound MSP9. The binding domain lies in the cysteine-rich N-proximal region of ABRA; binding was abolished by chymotrypsin treatment of erythrocytes. Native ABRA from P. falciparum-infected erythrocytes also bound band 3.","method":"Erythrocyte binding assays with recombinant ABRA fragments and deletion constructs; native protein binding assay; chymotrypsin treatment","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple deletion constructs, enzymatic disruption control, native protein confirmation; single lab but orthogonal approaches","pmids":["12076769"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2000,"finding":"MSP9 (ABRA) possesses chymotrypsin-like serine protease activity residing in the N-terminal portion of the protein. This protease activity was inhibited by chymostatin and PMSF but not by leupeptin. The highly charged C-terminal part of the protein is not required for protease activity.","method":"In vitro protease assay using fluorogenic and chromogenic substrates with recombinant ABRA fragments containing or lacking the putative active site; inhibitor profiling","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct enzymatic assay with substrates and inhibitors, but single lab, single study","pmids":["10699251"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1988,"finding":"MSP9 (ABRA/p101) is localised at the merozoite surface and within the parasitophorous vacuole, and becomes complexed to merozoites when schizonts rupture in the presence of immune serum.","method":"Protein sequencing and immunological characterisation (immunofluorescence, immunoblot) of cloned antigen","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization established by immunofluorescence and biochemical fractionation; replicated in subsequent studies","pmids":["3042768"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"Camp; FCR3"}]},{"year":2001,"finding":"Synthetic 20-mer peptides covering the MSP9 N-terminal region (residues 121–240) specifically bind erythrocytes with high affinity (Kd 70–180 nM). Peptides 2148 and 2149 inhibit erythrocyte invasion by merozoites in vitro. Hydrophobic interactions contribute to erythrocyte binding.","method":"Erythrocyte binding assays with synthetic peptides; in vitro invasion inhibition assay; affinity measurements","journal":"Vaccine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional invasion inhibition with multiple peptides and quantitative binding data; single lab","pmids":["11483276"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1998,"finding":"Antibodies against two MSP9 (ABRA) peptide constructs (AB-1 and AB-5) inhibited merozoite reinvasion of human erythrocytes in vitro by approximately 90%, establishing that epitopes in the hydrophilic regions of MSP9 can functionally block invasion.","method":"In vitro invasion inhibition assay using rabbit antipeptide antibodies; PBMC proliferation assay; immunoblot","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional invasion inhibition with quantitative outcome; single lab, two peptide constructs tested","pmids":["9596765"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"finding":"MSP9 was identified as a component of the MSP1-associated surface complex on P. falciparum merozoites. Anti-MSP1 pulldown from merozoite lysate co-precipitated MSP9 along with MSP3, MSP6, MSP7, RhopH3, RhopH1, RAP-1, and RAP-2, with the complex specifically present at schizont/merozoite stages but not at the ring stage.","method":"Anti-MSP1 and anti-RhopH3 antibody pulldown from merozoite lysate followed by tandem mass spectrometry","journal":"Journal of proteome research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-identified co-precipitate with reciprocal pulldowns; single lab but orthogonal antibodies used","pmids":["21175202"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"MSP9 (PfMSP-9) interacts with PfMSP-165 (encompassing p38 and p42 regions of MSP1) but not with PfMSP-119. Among the proteins of the MSP1 complex, PfMSP-9 and PfMSP-6 bound to human erythrocytes.","method":"Recombinant protein interaction assays; erythrocyte binding assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assays with defined recombinant constructs mapping the interaction domain; single lab","pmids":["29511044"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"finding":"P. berghei MSP-9 harbors erythrocyte binding activity and serine protease activity. Immunization of BALB/c mice with a recombinant PbMSP-9 fragment in alum induced protection against homologous P. berghei NK65 blood-stage challenge.","method":"Erythrocyte binding assay; protease activity assay; mouse immunization and challenge model","journal":"Vaccine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays (binding, enzymatic, in vivo protection) in a single study; single lab","pmids":["18272263"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":"NK65"}]},{"year":2002,"finding":"MSP9 orthologs in P. vivax, P. cynomolgi, and P. knowlesi are merozoite surface proteins with four conserved cysteine residues near the N-terminus (also conserved in P. falciparum ABRA/MSP9), suggesting conserved structural and possibly functional characteristics across the MSP9 family. Rabbit antisera against recombinant N-termini of PkMSP9 and PvMSP9 cross-reacted with counterpart proteins by immunofluorescence and immunoblot.","method":"PCR cloning, sequence analysis, recombinant protein expression, immunofluorescence assay, immunoblot with cross-reactive antisera","journal":"Molecular and biochemical parasitology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — characterisation of orthologues by sequence and cross-reactive antibodies; no direct functional experiment on the P. falciparum gene","pmids":["11849704"],"is_preprint":false,"attribution":[{"species":"Plasmodium vivax","strain":""},{"species":"Plasmodium cynomolgi","strain":""},{"species":"Plasmodium knowlesi","strain":""}]}],"current_model":"MSP9 (PF3D7_1228600/ABRA) is a merozoite surface and parasitophorous vacuole protein that participates in erythrocyte invasion by directly binding the exofacial 5ABC region of band 3 through its N-terminal cysteine-rich domain and a second region (Delta2); it exists on the merozoite surface as a stable co-ligand complex with MSP1(42), with MSP9's Delta1a and Delta2 regions contacting MSP1(19), forming a ternary MSP1–MSP9–band 3 complex; additionally, MSP9 possesses intrinsic chymotrypsin-like serine protease activity residing in its N-terminal portion, and is a member of the broader MSP1-associated surface complex that includes MSP3, MSP6, MSP7, and rhoptry proteins."},"narrative":{"mechanistic_narrative":"MSP9 (PF3D7_1228600, also called ABRA/p101) is a P. falciparum merozoite surface and parasitophorous vacuole protein that contributes to erythrocyte invasion by directly engaging the host band 3 receptor [PMID:12076769, PMID:14630931, PMID:3042768]. Its cysteine-rich N-terminal region binds the exofacial 5ABC region of erythrocyte band 3 specifically and saturably, selecting band 3 over glycophorin A/B and spectrin, with binding abolished by chymotrypsin pretreatment of erythrocytes; two regions of MSP9, Delta1 and Delta2, mediate this interaction and inhibit reinvasion in vitro [PMID:12076769, PMID:14630931]. MSP9 does not act alone at the erythrocyte surface: it forms a stable co-ligand complex with MSP1(42), with the MSP9 Delta1a and Delta2 regions contacting the C-terminal MSP1(19)/MSP1(65) portions of MSP1, assembling a ternary MSP1–MSP9–band 3 assembly in which the same MSP9 regions used for complex assembly are those that bind band 3 [PMID:14630931, PMID:16289042, PMID:29511044]. MSP9 is a broader component of the schizont/merozoite-stage MSP1-associated surface complex that also includes MSP3, MSP6, MSP7, and rhoptry proteins [PMID:21175202]. Independently of its receptor-binding role, MSP9 possesses intrinsic chymotrypsin-like serine protease activity residing in its N-terminal portion and inhibited by chymostatin and PMSF but not leupeptin [PMID:10699251]. Antibodies and synthetic peptides directed at the N-terminal region block merozoite reinvasion, marking MSP9 as an invasion-relevant, vaccine-candidate antigen [PMID:11483276, PMID:9596765].","teleology":[{"year":1988,"claim":"Establishing where MSP9 resides was the first step in placing it in the invasion pathway; localization to the merozoite surface and parasitophorous vacuole positioned it at the host–parasite interface.","evidence":"Protein sequencing and immunofluorescence/immunoblot characterization of the cloned antigen (ABRA/p101)","pmids":["3042768"],"confidence":"Medium","gaps":["Does not define a molecular activity or receptor","Complex membership not addressed"],"attribution":[{"species":"Plasmodium falciparum","strain":"Camp; FCR3"}]},{"year":2000,"claim":"The question of whether MSP9 had an enzymatic function was answered by demonstrating intrinsic chymotrypsin-like serine protease activity in its N-terminal portion, revealing a catalytic role distinct from receptor binding.","evidence":"In vitro protease assays with fluorogenic/chromogenic substrates and inhibitor profiling using recombinant ABRA fragments","pmids":["10699251"],"confidence":"Medium","gaps":["No physiological substrate identified","Single lab, single study","Relationship of protease activity to invasion not tested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2001,"claim":"To test whether the N-terminal region has invasion-relevant erythrocyte affinity, high-affinity binding peptides were mapped and shown to block invasion, functionally implicating that region in host cell engagement.","evidence":"Erythrocyte binding assays and in vitro invasion inhibition with synthetic 20-mer peptides plus affinity measurements","pmids":["11483276"],"confidence":"Medium","gaps":["Did not identify the erythrocyte receptor","Peptide binding may not reflect native protein conformation"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":1998,"claim":"Whether MSP9 epitopes are functionally accessible during invasion was addressed by showing antipeptide antibodies inhibit reinvasion by ~90%, marking MSP9 as an invasion-blocking target.","evidence":"In vitro invasion inhibition using rabbit antipeptide antibodies with immunoblot confirmation","pmids":["9596765"],"confidence":"Medium","gaps":["Mechanism of inhibition (steric vs receptor blockade) not resolved","Two constructs only"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"claim":"The identity of the MSP9 erythrocyte receptor was resolved by demonstrating specific, saturable binding to band 3 through the cysteine-rich N-proximal region, distinguishing it from other candidate surface proteins.","evidence":"Erythrocyte binding assays with recombinant and native ABRA fragments, deletion constructs, and chymotrypsin controls","pmids":["12076769"],"confidence":"High","gaps":["Precise band 3 epitope not yet mapped at this stage","Contribution of protease activity to binding untested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"claim":"Building on receptor identity, the specific band 3 subregion and the co-ligand nature of MSP9 were defined, showing MSP9 Delta1/Delta2 target the exofacial 5ABC region and that MSP9 acts together with MSP1(42).","evidence":"Recombinant binding assays, soluble 5ABC competition, invasion inhibition, and co-IP of native MSP9 and MSP1(42)","pmids":["14630931"],"confidence":"High","gaps":["Stoichiometry/architecture of the co-ligand complex not resolved","How complex assembly relates to invasion kinetics unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"claim":"The molecular interface for MSP9–MSP1 assembly was mapped, showing the same MSP9 Delta1a/Delta2 regions bind MSP1(19)/MSP1(42) and band 3, defining a unified ternary MSP1–MSP9–band 3 complex.","evidence":"Biochemical pulldown/binding assays with recombinant MSP9 deletion constructs against native MSP1(19)/MSP1(42)","pmids":["16289042"],"confidence":"High","gaps":["Whether band 3 and MSP1 binding are simultaneous or competing on the same MSP9 regions not resolved","No structural model of the ternary complex"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"claim":"Conservation of MSP9 function was tested in a rodent model, showing the P. berghei ortholog retains both erythrocyte binding and protease activity and confers protection on immunization.","evidence":"Erythrocyte binding and protease assays plus mouse immunization/challenge with recombinant PbMSP-9","pmids":["18272263"],"confidence":"Medium","gaps":["Findings are for the P. berghei ortholog, not the P. falciparum gene","Correlate of protection not defined"],"attribution":[{"species":"Plasmodium berghei","strain":"NK65"}]},{"year":2010,"claim":"Placing MSP9 in its full surface context, proteomics showed it is a member of a larger stage-specific MSP1-associated complex that also recruits rhoptry proteins.","evidence":"Anti-MSP1 and anti-RhopH3 pulldowns from merozoite lysate followed by tandem mass spectrometry","pmids":["21175202"],"confidence":"Medium","gaps":["Direct MSP9 contacts with individual complex members beyond MSP1 not established","Functional role of MSP9 within the wider complex untested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Refining the MSP1 binding site, MSP9 was shown to interact with MSP1(65) (p38/p42) but not MSP1(19), and to be one of only two complex members that bind erythrocytes.","evidence":"Recombinant protein interaction and erythrocyte binding assays with defined MSP1 sub-fragments","pmids":["29511044"],"confidence":"Medium","gaps":["Apparent discrepancy with earlier MSP1(19) binding data not reconciled","Single lab"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The physiological substrate of MSP9's serine protease activity and its causal contribution to invasion versus its receptor-binding role remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No native protease substrate identified","No genetic knockout/knockdown phenotype for the P. falciparum gene in the corpus","No structure of the MSP1–MSP9–band 3 complex"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["MSP1-associated merozoite surface complex (with MSP3, MSP6, MSP7, RhopH3, RhopH1, RAP-1, RAP-2)","MSP1(42)-MSP9 co-ligand complex","ternary MSP1-MSP9-band 3 complex"],"partners":["MSP1 (MSP1(42)/MSP1(19)/MSP1(65) P38-P42)","ERYTHROCYTE BAND 3 (EXOFACIAL 5ABC REGION)"],"other_free_text":["N-terminal cysteine-rich region mediates band 3 binding and is chymotrypsin-sensitive on the erythrocyte side","Delta1a and Delta2 regions mediate MSP1 binding; Delta1 and Delta2 mediate band 3 binding","Chymotrypsin-like serine protease activity inhibited by chymostatin and PMSF but not leupeptin; C-terminal charged region dispensable for catalysis","Antipeptide antibodies and synthetic N-terminal peptides inhibit merozoite reinvasion in vitro (vaccine-candidate antigen)","Orthologs characterized in P. berghei, P. vivax, P. cynomolgi, and P. knowlesi; four conserved N-terminal cysteines"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"14630931","id":"PMC_14630931","title":"A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14630931","citation_count":90,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11849704","id":"PMC_11849704","title":"Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum.","date":"2002","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11849704","citation_count":46,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11483276","id":"PMC_11483276","title":"Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity.","date":"2001","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/11483276","citation_count":46,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"3042768","id":"PMC_3042768","title":"Primary structure of a Plasmodium falciparum malaria antigen located at the merozoite surface and within the parasitophorous vacuole.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3042768","citation_count":45,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24244763","id":"PMC_24244763","title":"Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.","date":"2013","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24244763","citation_count":44,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22649493","id":"PMC_22649493","title":"Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22649493","citation_count":40,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18832003","id":"PMC_18832003","title":"Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.","date":"2008","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/18832003","citation_count":38,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15121316","id":"PMC_15121316","title":"Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.","date":"2004","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/15121316","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21175202","id":"PMC_21175202","title":"Proteome analysis reveals a large merozoite surface protein-1 associated complex on the Plasmodium falciparum merozoite surface.","date":"2010","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/21175202","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18820076","id":"PMC_18820076","title":"Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes.","date":"2008","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/18820076","citation_count":30,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25157665","id":"PMC_25157665","title":"Human erythrocyte band 3 functions as a receptor for the sialic acid-independent invasion of Plasmodium falciparum. Role of the RhopH3-MSP1 complex.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25157665","citation_count":28,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24373342","id":"PMC_24373342","title":"Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.","date":"2013","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24373342","citation_count":26,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12797974","id":"PMC_12797974","title":"Phylogenetic analysis of CSP and MSP-9 gene sequences demonstrates the close relationship of Plasmodium coatneyi to Plasmodium knowlesi.","date":"2003","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12797974","citation_count":25,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12076769","id":"PMC_12076769","title":"Amino terminus of Plasmodium falciparum acidic basic repeat antigen interacts with the erythrocyte membrane through band 3 protein.","date":"2002","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12076769","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16289042","id":"PMC_16289042","title":"Two Plasmodium falciparum merozoite proteins binding to erythrocyte band 3 form a direct complex.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16289042","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26788998","id":"PMC_26788998","title":"In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26788998","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"9596765","id":"PMC_9596765","title":"Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues.","date":"1998","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9596765","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35141172","id":"PMC_35141172","title":"Antigen Discovery in Circulating Extracellular Vesicles From Plasmodium vivax Patients.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/35141172","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"10699251","id":"PMC_10699251","title":"Expression and characterisation of Plasmodium falciparum acidic basic repeat antigen expressed in Escherichia coli.","date":"2000","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/10699251","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20189487","id":"PMC_20189487","title":"Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.","date":"2010","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/20189487","citation_count":20,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31214627","id":"PMC_31214627","title":"Reduced Transplacental Transfer of Antimalarial Antibodies in Kenyan HIV-Exposed Uninfected Infants.","date":"2019","source":"Open forum infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31214627","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24044894","id":"PMC_24044894","title":"The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species.","date":"2013","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24044894","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30509693","id":"PMC_30509693","title":"Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9.","date":"2018","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/30509693","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32096238","id":"PMC_32096238","title":"Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.","date":"2020","source":"Parasite immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32096238","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29511044","id":"PMC_29511044","title":"Protein-protein interaction studies reveal the Plasmodium falciparum merozoite surface protein-1 region involved in a complex formation that binds to human erythrocytes.","date":"2018","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29511044","citation_count":10,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32751598","id":"PMC_32751598","title":"Protective Immunity Induced by Virus-Like Particle Containing Merozoite Surface Protein 9 of Plasmodium berghei.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/32751598","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19463923","id":"PMC_19463923","title":"Sequence diversity and evolutionary dynamics of the dimorphic antigen merozoite surface protein-6 and other Msp genes of Plasmodium falciparum.","date":"2009","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/19463923","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","PfMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32711079","id":"PMC_32711079","title":"Structural diversity, natural selection and intragenic recombination in the Plasmodium vivax merozoite surface protein 9 locus in Thailand.","date":"2020","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32711079","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18272263","id":"PMC_18272263","title":"Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model.","date":"2008","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/18272263","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9","PbMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33547377","id":"PMC_33547377","title":"Immunoglobulin G responses to variant forms of Plasmodium vivax merozoite surface protein 9 upon natural infection in Thailand.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33547377","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9","PvMSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"35214662","id":"PMC_35214662","title":"Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1.","date":"2022","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/35214662","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41128014","id":"PMC_41128014","title":"Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens.","date":"2026","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/41128014","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"42405907","id":"PMC_42405907","title":"Immunodominant B-cell epitopes for precision surveillance of Plasmodium vivax malaria.","date":"2026","source":"Emerging microbes & infections","url":"https://pubmed.ncbi.nlm.nih.gov/42405907","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["MSP9","merozoite surface protein 9"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20682,"output_tokens":3188,"usd":0.054933,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8899,"output_tokens":4157,"usd":0.07421,"stage2_stop_reason":"end_turn"},"total_usd":0.129143,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Two regions of MSP9 (MSP9/Delta1 and MSP9/Delta2) interact directly with the 5ABC exofacial region of erythrocyte band 3 during P. falciparum erythrocyte invasion. Soluble 5ABC blocked MSP9 binding to erythrocytes, and recombinant MSP9/Delta1 and MSP9/Delta2 inhibited P. falciparum reinvasion in vitro. Native MSP9 and MSP1(42) exist as a stable co-ligand complex that together targets the band 3 receptor.\",\n      \"method\": \"Recombinant protein binding assays, erythrocyte invasion inhibition assay, co-immunoprecipitation of native proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding assays with recombinant and native protein, functional invasion inhibition, soluble competitor blocking, replicated across multiple MSP9 constructs in a single rigorous study\",\n      \"pmids\": [\"14630931\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A major MSP9-binding site on MSP1 is located within the 19 kDa C-terminal domain (MSP1(19)). Two specific regions of MSP9, Delta1a and Delta2, interact with native MSP1(19) and with MSP1(42). The regions of MSP1 and MSP9 that bind the erythrocyte band 3 receptor are the same regions responsible for assembling the co-ligand complex, forming a ternary complex of MSP1–MSP9–band 3 during invasion.\",\n      \"method\": \"Biochemical pulldown/binding assays with recombinant MSP9 deletion constructs and native MSP1(19)/MSP1(42)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple deletion constructs with reciprocal binding assays, building directly on prior replicated results; single lab but two orthogonal binding approaches\",\n      \"pmids\": [\"16289042\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The amino terminus of MSP9 (also called ABRA) interacts with erythrocyte band 3 protein in a dose-dependent and saturable manner. Among band 3, glycophorin A, glycophorin B, and spectrin, only band 3 bound MSP9. The binding domain lies in the cysteine-rich N-proximal region of ABRA; binding was abolished by chymotrypsin treatment of erythrocytes. Native ABRA from P. falciparum-infected erythrocytes also bound band 3.\",\n      \"method\": \"Erythrocyte binding assays with recombinant ABRA fragments and deletion constructs; native protein binding assay; chymotrypsin treatment\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple deletion constructs, enzymatic disruption control, native protein confirmation; single lab but orthogonal approaches\",\n      \"pmids\": [\"12076769\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MSP9 (ABRA) possesses chymotrypsin-like serine protease activity residing in the N-terminal portion of the protein. This protease activity was inhibited by chymostatin and PMSF but not by leupeptin. The highly charged C-terminal part of the protein is not required for protease activity.\",\n      \"method\": \"In vitro protease assay using fluorogenic and chromogenic substrates with recombinant ABRA fragments containing or lacking the putative active site; inhibitor profiling\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct enzymatic assay with substrates and inhibitors, but single lab, single study\",\n      \"pmids\": [\"10699251\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"MSP9 (ABRA/p101) is localised at the merozoite surface and within the parasitophorous vacuole, and becomes complexed to merozoites when schizonts rupture in the presence of immune serum.\",\n      \"method\": \"Protein sequencing and immunological characterisation (immunofluorescence, immunoblot) of cloned antigen\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization established by immunofluorescence and biochemical fractionation; replicated in subsequent studies\",\n      \"pmids\": [\"3042768\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"Camp; FCR3\"}]\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Synthetic 20-mer peptides covering the MSP9 N-terminal region (residues 121–240) specifically bind erythrocytes with high affinity (Kd 70–180 nM). Peptides 2148 and 2149 inhibit erythrocyte invasion by merozoites in vitro. Hydrophobic interactions contribute to erythrocyte binding.\",\n      \"method\": \"Erythrocyte binding assays with synthetic peptides; in vitro invasion inhibition assay; affinity measurements\",\n      \"journal\": \"Vaccine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional invasion inhibition with multiple peptides and quantitative binding data; single lab\",\n      \"pmids\": [\"11483276\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Antibodies against two MSP9 (ABRA) peptide constructs (AB-1 and AB-5) inhibited merozoite reinvasion of human erythrocytes in vitro by approximately 90%, establishing that epitopes in the hydrophilic regions of MSP9 can functionally block invasion.\",\n      \"method\": \"In vitro invasion inhibition assay using rabbit antipeptide antibodies; PBMC proliferation assay; immunoblot\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional invasion inhibition with quantitative outcome; single lab, two peptide constructs tested\",\n      \"pmids\": [\"9596765\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MSP9 was identified as a component of the MSP1-associated surface complex on P. falciparum merozoites. Anti-MSP1 pulldown from merozoite lysate co-precipitated MSP9 along with MSP3, MSP6, MSP7, RhopH3, RhopH1, RAP-1, and RAP-2, with the complex specifically present at schizont/merozoite stages but not at the ring stage.\",\n      \"method\": \"Anti-MSP1 and anti-RhopH3 antibody pulldown from merozoite lysate followed by tandem mass spectrometry\",\n      \"journal\": \"Journal of proteome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-identified co-precipitate with reciprocal pulldowns; single lab but orthogonal antibodies used\",\n      \"pmids\": [\"21175202\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MSP9 (PfMSP-9) interacts with PfMSP-165 (encompassing p38 and p42 regions of MSP1) but not with PfMSP-119. Among the proteins of the MSP1 complex, PfMSP-9 and PfMSP-6 bound to human erythrocytes.\",\n      \"method\": \"Recombinant protein interaction assays; erythrocyte binding assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assays with defined recombinant constructs mapping the interaction domain; single lab\",\n      \"pmids\": [\"29511044\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"P. berghei MSP-9 harbors erythrocyte binding activity and serine protease activity. Immunization of BALB/c mice with a recombinant PbMSP-9 fragment in alum induced protection against homologous P. berghei NK65 blood-stage challenge.\",\n      \"method\": \"Erythrocyte binding assay; protease activity assay; mouse immunization and challenge model\",\n      \"journal\": \"Vaccine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays (binding, enzymatic, in vivo protection) in a single study; single lab\",\n      \"pmids\": [\"18272263\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"NK65\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MSP9 orthologs in P. vivax, P. cynomolgi, and P. knowlesi are merozoite surface proteins with four conserved cysteine residues near the N-terminus (also conserved in P. falciparum ABRA/MSP9), suggesting conserved structural and possibly functional characteristics across the MSP9 family. Rabbit antisera against recombinant N-termini of PkMSP9 and PvMSP9 cross-reacted with counterpart proteins by immunofluorescence and immunoblot.\",\n      \"method\": \"PCR cloning, sequence analysis, recombinant protein expression, immunofluorescence assay, immunoblot with cross-reactive antisera\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — characterisation of orthologues by sequence and cross-reactive antibodies; no direct functional experiment on the P. falciparum gene\",\n      \"pmids\": [\"11849704\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium vivax\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium cynomolgi\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium knowlesi\", \"strain\": \"\"}\n      ]\n    }\n  ],\n  \"current_model\": \"MSP9 (PF3D7_1228600/ABRA) is a merozoite surface and parasitophorous vacuole protein that participates in erythrocyte invasion by directly binding the exofacial 5ABC region of band 3 through its N-terminal cysteine-rich domain and a second region (Delta2); it exists on the merozoite surface as a stable co-ligand complex with MSP1(42), with MSP9's Delta1a and Delta2 regions contacting MSP1(19), forming a ternary MSP1–MSP9–band 3 complex; additionally, MSP9 possesses intrinsic chymotrypsin-like serine protease activity residing in its N-terminal portion, and is a member of the broader MSP1-associated surface complex that includes MSP3, MSP6, MSP7, and rhoptry proteins.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MSP9 (PF3D7_1228600, also called ABRA/p101) is a P. falciparum merozoite surface and parasitophorous vacuole protein that contributes to erythrocyte invasion by directly engaging the host band 3 receptor [#2, #0, #4]. Its cysteine-rich N-terminal region binds the exofacial 5ABC region of erythrocyte band 3 specifically and saturably, selecting band 3 over glycophorin A/B and spectrin, with binding abolished by chymotrypsin pretreatment of erythrocytes; two regions of MSP9, Delta1 and Delta2, mediate this interaction and inhibit reinvasion in vitro [#2, #0]. MSP9 does not act alone at the erythrocyte surface: it forms a stable co-ligand complex with MSP1(42), with the MSP9 Delta1a and Delta2 regions contacting the C-terminal MSP1(19)/MSP1(65) portions of MSP1, assembling a ternary MSP1\\u2013MSP9\\u2013band 3 assembly in which the same MSP9 regions used for complex assembly are those that bind band 3 [#0, #1, #8]. MSP9 is a broader component of the schizont/merozoite-stage MSP1-associated surface complex that also includes MSP3, MSP6, MSP7, and rhoptry proteins [#7]. Independently of its receptor-binding role, MSP9 possesses intrinsic chymotrypsin-like serine protease activity residing in its N-terminal portion and inhibited by chymostatin and PMSF but not leupeptin [#3]. Antibodies and synthetic peptides directed at the N-terminal region block merozoite reinvasion, marking MSP9 as an invasion-relevant, vaccine-candidate antigen [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Establishing where MSP9 resides was the first step in placing it in the invasion pathway; localization to the merozoite surface and parasitophorous vacuole positioned it at the host\\u2013parasite interface.\",\n      \"evidence\": \"Protein sequencing and immunofluorescence/immunoblot characterization of the cloned antigen (ABRA/p101)\",\n      \"pmids\": [\"3042768\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not define a molecular activity or receptor\", \"Complex membership not addressed\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"Camp; FCR3\"}]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The question of whether MSP9 had an enzymatic function was answered by demonstrating intrinsic chymotrypsin-like serine protease activity in its N-terminal portion, revealing a catalytic role distinct from receptor binding.\",\n      \"evidence\": \"In vitro protease assays with fluorogenic/chromogenic substrates and inhibitor profiling using recombinant ABRA fragments\",\n      \"pmids\": [\"10699251\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No physiological substrate identified\", \"Single lab, single study\", \"Relationship of protease activity to invasion not tested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"To test whether the N-terminal region has invasion-relevant erythrocyte affinity, high-affinity binding peptides were mapped and shown to block invasion, functionally implicating that region in host cell engagement.\",\n      \"evidence\": \"Erythrocyte binding assays and in vitro invasion inhibition with synthetic 20-mer peptides plus affinity measurements\",\n      \"pmids\": [\"11483276\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the erythrocyte receptor\", \"Peptide binding may not reflect native protein conformation\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Whether MSP9 epitopes are functionally accessible during invasion was addressed by showing antipeptide antibodies inhibit reinvasion by ~90%, marking MSP9 as an invasion-blocking target.\",\n      \"evidence\": \"In vitro invasion inhibition using rabbit antipeptide antibodies with immunoblot confirmation\",\n      \"pmids\": [\"9596765\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of inhibition (steric vs receptor blockade) not resolved\", \"Two constructs only\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The identity of the MSP9 erythrocyte receptor was resolved by demonstrating specific, saturable binding to band 3 through the cysteine-rich N-proximal region, distinguishing it from other candidate surface proteins.\",\n      \"evidence\": \"Erythrocyte binding assays with recombinant and native ABRA fragments, deletion constructs, and chymotrypsin controls\",\n      \"pmids\": [\"12076769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise band 3 epitope not yet mapped at this stage\", \"Contribution of protease activity to binding untested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Building on receptor identity, the specific band 3 subregion and the co-ligand nature of MSP9 were defined, showing MSP9 Delta1/Delta2 target the exofacial 5ABC region and that MSP9 acts together with MSP1(42).\",\n      \"evidence\": \"Recombinant binding assays, soluble 5ABC competition, invasion inhibition, and co-IP of native MSP9 and MSP1(42)\",\n      \"pmids\": [\"14630931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry/architecture of the co-ligand complex not resolved\", \"How complex assembly relates to invasion kinetics unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The molecular interface for MSP9\\u2013MSP1 assembly was mapped, showing the same MSP9 Delta1a/Delta2 regions bind MSP1(19)/MSP1(42) and band 3, defining a unified ternary MSP1\\u2013MSP9\\u2013band 3 complex.\",\n      \"evidence\": \"Biochemical pulldown/binding assays with recombinant MSP9 deletion constructs against native MSP1(19)/MSP1(42)\",\n      \"pmids\": [\"16289042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether band 3 and MSP1 binding are simultaneous or competing on the same MSP9 regions not resolved\", \"No structural model of the ternary complex\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Conservation of MSP9 function was tested in a rodent model, showing the P. berghei ortholog retains both erythrocyte binding and protease activity and confers protection on immunization.\",\n      \"evidence\": \"Erythrocyte binding and protease assays plus mouse immunization/challenge with recombinant PbMSP-9\",\n      \"pmids\": [\"18272263\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Findings are for the P. berghei ortholog, not the P. falciparum gene\", \"Correlate of protection not defined\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"NK65\"}]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Placing MSP9 in its full surface context, proteomics showed it is a member of a larger stage-specific MSP1-associated complex that also recruits rhoptry proteins.\",\n      \"evidence\": \"Anti-MSP1 and anti-RhopH3 pulldowns from merozoite lysate followed by tandem mass spectrometry\",\n      \"pmids\": [\"21175202\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MSP9 contacts with individual complex members beyond MSP1 not established\", \"Functional role of MSP9 within the wider complex untested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Refining the MSP1 binding site, MSP9 was shown to interact with MSP1(65) (p38/p42) but not MSP1(19), and to be one of only two complex members that bind erythrocytes.\",\n      \"evidence\": \"Recombinant protein interaction and erythrocyte binding assays with defined MSP1 sub-fragments\",\n      \"pmids\": [\"29511044\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apparent discrepancy with earlier MSP1(19) binding data not reconciled\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The physiological substrate of MSP9's serine protease activity and its causal contribution to invasion versus its receptor-binding role remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No native protease substrate identified\", \"No genetic knockout/knockdown phenotype for the P. falciparum gene in the corpus\", \"No structure of the MSP1\\u2013MSP9\\u2013band 3 complex\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004252\", \"supporting_discovery_ids\": [3, 9]},\n      {\"term_id\": \"GO:0030246\", \"supporting_discovery_ids\": [2, 0, 5, 8]},\n      {\"term_id\": \"GO:0005102\", \"supporting_discovery_ids\": [0, 1, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0009986\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0044409\", \"supporting_discovery_ids\": [0, 2, 5, 6]}\n    ],\n    \"complexes\": [\n      \"MSP1-associated merozoite surface complex (with MSP3, MSP6, MSP7, RhopH3, RhopH1, RAP-1, RAP-2)\",\n      \"MSP1(42)-MSP9 co-ligand complex\",\n      \"ternary MSP1-MSP9-band 3 complex\"\n    ],\n    \"partners\": [\n      \"MSP1 (MSP1(42)/MSP1(19)/MSP1(65) p38-p42)\",\n      \"erythrocyte band 3 (exofacial 5ABC region)\"\n    ],\n    \"other_free_text\": [\n      \"N-terminal cysteine-rich region mediates band 3 binding and is chymotrypsin-sensitive on the erythrocyte side\",\n      \"Delta1a and Delta2 regions mediate MSP1 binding; Delta1 and Delta2 mediate band 3 binding\",\n      \"Chymotrypsin-like serine protease activity inhibited by chymostatin and PMSF but not leupeptin; C-terminal charged region dispensable for catalysis\",\n      \"Antipeptide antibodies and synthetic N-terminal peptides inhibit merozoite reinvasion in vitro (vaccine-candidate antigen)\",\n      \"Orthologs characterized in P. berghei, P. vivax, P. cynomolgi, and P. knowlesi; four conserved N-terminal cysteines\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1228600","name":null,"product":"merozoite surface protein 9","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1443300","name":null,"product":"merozoite surface protein 9, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1448000","name":null,"product":"merozoite surface protein 9","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"MSP9","evaluation":null}